Live Breaking News & Updates on Severe Rheumatoid Arthritis

Stay updated with breaking news from Severe rheumatoid arthritis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GSK, MorphoSys' Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis

EQS-News: MorphoSys AG / Key word(s): MiscellaneousGSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis   27.10.2022 / 08:50 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich,. ....

United States , Thomas Biegi , Julia Neugebauer , Eamonn Nolan , Exchange Commission , American College Of Rheumatology , Program For Otilimab , Distribution Services , Morphosy Licensing Partner , Provides Update , Severe Rheumatoid Arthritis , Severe Rheumatoid , American College , Janus Kinase , Morphosy Annual Report , Corporate News , Regulatory Announcements ,

ASIC sues MLC Life for multiple insurance failures

The corporate regulator alleges MLC Life Insurance, in some instances, failed to pay life insurance benefits, notify on premium rises or refund premiums, amongst other breaches affecting over 260,000 customers. ....

Sarah Court , Investments Commission , Royal Commission , Australian Securities , Federal Court , Severe Rheumatoid Arthriti , Severe Rheumatoid Arthritis , Sarah Court ,

ASIC sues MLC Life for multiple insurance failures

The corporate regulator alleges MLC Life Insurance, in some instances, failed to pay life insurance benefits, notify on premium rises or refund premiums, amongst other breaches affecting over 260,000 customers. ....

Sarah Court , Investments Commission , Royal Commission , Australian Securities , Federal Court , Life Insurance , Severe Rheumatoid Arthriti , Severe Rheumatoid Arthritis ,